Company profile
Annual Report 2014
LEI
cee stock exchange group
Issuers / Issuers News
Article print

13 Sep 2013 14:15 
Extraordinary Information
Marketing authorisation for biosimilar infliximab in EU
Attached documents:
Releaser: EGIS Pharmaceuticals PLC
Date Issued: 13 Sep 2013
 
Actual
2015 average
Name
Price
%
Turn. (tEUR)
ˇ
1,005
-1.28
15
-
205
0.00
11
ˇ
160
-1.23
78
ˇ
7,961
-0.05
4
-
21,300
0.00
0
^
771
+0.13
1
ˇ
2,320
-0.85
5
ˇ
14,390
-0.83
859
^
404
+0.75
612
^
5,800
+0.17
948
ˇ
350
-0.57
77
^
1,270
+0.08
0
^
4,390
+0.34
1,758
^
95
+1.06
1
Change %: to baseprice
Data delayed by 15 minutes
Indices
Index
Value
Change %
BUX
22,406.79
24.82 (0.11)
1,687.07
-5.21 (-0.31)
1,239.97
-2.05 (-0.17)
1,229.29
-0.76 (-0.06)
1,868.16
13.87 (0.75)